Question for webinar, page-22

  1. 1,790 Posts.
    lightbulb Created with Sketch. 156
    The cr papers and the recent commentary in the webinar show a renaissance for ALT. It has recognised it is an R & D company and will do a licence deal with an mjor to market both The PeriCoach and the Burette. The share issues to Dr Mansour and others are not only capital raising but to takeover protect the company from low ball offers.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.